Lethality of Alzheimer Disease and Its Impact on Nursing Home Placement
The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
This analysis evaluates the progression of Alzheimer disease (AD) severity and compares the life expectancy and nursing home placement rates for AD patients with the same measures in the general population. Data from the Consortium to Establish a Registry for Alzheimer Disease were analyzed to estimate expected survival, time spent in each Clinical Dementia Rating stage, and nursing home admission rate for a hypothetical cohort of patients aged 70 years with new-onset AD. Corresponding estimates for the US general population were calculated from the 2004 National Nursing Home Survey and the 2003 life table estimates from the US Census Bureau. Deaths from all causes by age 80 years are expected in 61% of AD patients and in 30% of the general population. From the age of 70 to 80 years, a typical AD patient spends 4 years at Clinical Dementia Rating stage 3 (severe), 3 years at stage 2 (moderate), and 3 years at stage 1 (mild). Nursing home admission by the age of 80 years is expected for approximately 75% of surviving AD patients, but for only 4% of the general population. Among persons aged > or =65 years, reported age-adjusted and sex-adjusted mortality rates for AD increased to 33% from 1999 to 2004.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“among people age 70, 61% of those with Alzheimer's dementia are expected to die before age 80 compared with 30% of people without Alzheimer's dementia.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [384]
In the citing paper
“At age 80, approximately 75% of people with Alzheimer's dementia live in a nursing home compared with only 4% of the general population age 80. 384”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [384]
In the citing paper
“A person who lives from age 70 to age 80 with Alzheimer's dementia will spend an average of 40% of this time in the severe stage.384”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [384]
In the citing paper
“among people age 70, 61% of those with Alzheimer's dementia are expected to die before age 80 compared with 30% of people without Alzheimer's dementia.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [414]
In the citing paper
“A person who lives from age 70 to age 80 with Alzheimer's dementia will spend an average of 40% of this time in the severe stage.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [414]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Forecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370 · cited 11×
“A substantial impact on life expectancy is manifested early in the course of AD.”
BackgroundInfluentialSelf-citationThe incidence of dementia: A meta-analysis
Jorm, A. F., & Jolley, D. (1998) · Neurology · doi:10.1212/wnl.51.3.728 · Cited by 903
Morris, J. C., Storandt, M., McKeel, D. W., Rubin, E. H., Price, J. L., Grant, E. A., & Berg, L. (1996) · Neurology · doi:10.1212/wnl.46.3.707 · Cited by 603
Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease
Mittelman, M. S., Haley, W. E., Clay, O. J., & Roth, D. L. (2006) · Neurology · doi:10.1212/01.wnl.0000242727.81172.91 · Cited by 602 · cited 1×
“Improving availability of and access to caregiver support and home care services may reduce the need for patient care in institutionalized settings.(41) FIGURE 1.”
BackgroundSurvival after Initial Diagnosis of Alzheimer Disease
Larson, E. B., Shadlen, M.-F., Wang, L., McCormick, W. C., Bowen, J. D., Teri, L., & Kukull, W. A. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-7-200404060-00008 · Cited by 543
Seshadri, S., Wolf, P. A., Beiser, A., Au, R., McNulty, K., White, R., & D'Agostino, R. B. (1997) · Neurology · doi:10.1212/wnl.49.6.1498 · Cited by 489 · cited 2×
“In contrast, the corresponding risk for developing AD is nearly 12%.(43) Among men aged 70 years, the remaining lifetime risk for developing prostate cancer is 12%, with the corresponding AD risk being lower, at 6%.”
BackgroundMorris, J. C., McKeel, D. W., Storandt, M., Rubin, E. H., Price, J. L., Grant, E. A., Ball, M. J., & Berg, L. (1991) · Neurology · doi:10.1212/wnl.41.4.469 · Cited by 473
Survival Following a Diagnosis of Alzheimer Disease
Brookmeyer, R., Corrada, M. M., Curriero, F. C., & Kawas, C. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1764 · Cited by 407 · cited 12×
“A substantial impact on life expectancy is manifested early in the course of AD.”
BackgroundInfluentialUnited States life tables, 2003.
Arias, E. (2006) · PubMed · Cited by 375
Alzheimer Disease and Mortality: A 15-Year Epidemiological Study
Ganguli, M., Dodge, H. H., Shen, C., Pandav, R. S., & DeKosky, S. T. (2005) · Archives of Neurology · doi:10.1001/archneur.62.5.779 · Cited by 297
Cited by
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
“Regardless of the cause of death, among people age 70, 61 percent of those with Alzheimer’s are expected to die before age 80 compared with 30 percent of people without Alzheimer’s [192].”
Influential2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
“On average, a person with AD will spend more years (40% of the total number of years with AD) in the most severe stage of the disease than in any other stage [119].”
Influential2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
“At age 80, approximately 75 percent of people living with Alzheimer’s dementia are expected to live in a nursing home compared with only 4 percent of the general population at age 80 [258].”
Influential2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
2022 Alzheimer's disease facts and figures
(2022) · Alzheimer's & Dementia · doi:10.1002/alz.12638 · Cited by 2,341
2021 Alzheimer's disease facts and figures
(2021) · Alzheimer's & Dementia · doi:10.1002/alz.12328 · Cited by 2,201
2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
“At age 80, approximately 75 percent of people living with Alzheimer’s dementia are expected to be in a nursing home compared with only 4 percent of the general population at age 80 [242].”
Influential2015 Alzheimer's disease facts and figures
Alzheimer's Association (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.02.003 · Cited by 1,635
2017 Alzheimer's disease facts and figures
(2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.02.001 · Cited by 1,311
“Irrespective of the cause of death, among people age 70, 61 percent of those with Alzheimer’s are expected to die before age 80 compared with 30 percent of people without Alzheimer’s [218].”
Influential2014 Alzheimer's disease facts and figures
Alzheimer's Association (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.02.001 · Cited by 1,020
“Regardless of the cause of death, among people aged 70 years, 61% of those with AD are expected to die before the age of 80 years compared with 30% of people without AD [157].”
Influential2012 Alzheimer's disease facts and figures Alzheimer's Association ∗
Thies, W., & Bleiler, L. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.02.001 · Cited by 982
2011 Alzheimer's disease facts and figures
Alzheimer's Association (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.02.004 · Cited by 908
“On average, a person with AD will spend more years (40% of the total number of years with AD) in the most severe stage of the disease than in any other stage [82].”
Influential2025 Alzheimer's disease facts and figures
(2025) · Alzheimer's & Dementia · doi:10.1002/alz.70235 · Cited by 474
Alzheimer’s Association Dementia Care Practice Recommendations
Fazio, S., Pace, D., Maslow, K., Zimmerman, S., & Kallmyer, B. (2018) · The Gerontologist · doi:10.1093/geront/gnx182 · Cited by 231
“Further, by age 80, 75% of people with Alzheimer’s dementia are admitted to a nursing home, compared with only 4% of the general population (Arrighi, Neumann, Lieberburg, & Townsend, 2010).”
BackgroundMitchell, S. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmcp1412652 · Cited by 195
Direct and indirect cost of managing alzheimer’s disease and related dementias in the United States
Deb, A., Thornton, J. D., Sambamoorthi, U., & Innes, K. (2017) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2017.1313118 · Cited by 190
“Nursing home costs On average, individuals with mild-to-moderate ADRD aged between 70 and 80 years spend 3 years in a nursing home while those with severe ADRD spend 4 years in nursing home [33].”
BackgroundLanguage impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors
Ferris, S., & Farlow, M. (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s39959 · Cited by 181
“Psychosocial burden of language impairment on patients and caregivers During the moderate to severe stages of AD, the patients’ language declines and deficits often result in a loss of ability to express their needs, which in turn affects their quality of life, prognosis, and social relationships, and can contribute s…”
BackgroundPalliative Care in Advanced Dementia
Eisenmann, Y., Golla, H., Schmidt, H., Voltz, R., & Perrar, K. M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00699 · Cited by 196
“People in the advanced stages of dementia spend most of their time in nursing homes (21).”
BackgroundDementia, Alzheimer’s Disease, and Mortality after Hemodialysis Initiation
McAdams‐DeMarco, M., Daubresse, M., Bae, S., Gross, A. L., Carlson, M. C., & Segev, D. L. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10150917 · Cited by 138
Galik, E., Resnick, B., Hammersla, M., & Brightwater, J. (2014) · The Gerontologist · doi:10.1093/geront/gnt108 · Cited by 123
Alzheimer’s disease and language impairments: social intervention and medical treatment
Kuca, K., Maresova, P., Klimova, B., Valis, M., & Hort, J. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s89714 · Cited by 122
“Furthermore, the loss of communication also has an enormous impact on their quality of life and considerably contributes to their and their caregiver’s burden.(16,18,28) Figure 1 exploration of research studies.”
BackgroundSpeech and language impairments in dementia
Klímová, B., & Kamil, K. (2016) · Journal of Applied Biomedicine · doi:10.1016/j.jab.2016.02.002 · Cited by 136
Xu, L., Liu, Y., He, H., Fields, N. L., Ivey, D. L., & Kan, C. (2021) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104334 · Cited by 97
Zhang, S., Zhen, K., Su, Q., Chen, Y., Lv, Y., & Yu, L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315700 · Cited by 123
“memory and cognitive impairments that interfere with daily primary physical activity, and the loss of the ability to take care of oneself, leading to death [6].”
BackgroundRahman, M., White, E. M., Thomas, K. S., & Jutkowitz, E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.22111 · Cited by 101
Han, L., Gill, T. M., Jones, B. L., & Allore, H. G. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv159 · Cited by 94
“Given the emerging literatures on the relationship between “normal” cognitive aging and risks of functional decline, mortality, hospitalization (4,5,19) and possibly, nursing home admissions (5,7), elucidating whether these relationships vary across different trajectories of cognitive aging is of great public health i…”
BackgroundComorbidity in Dementia: Update of an Ongoing Autopsy Study
Magaki, S., Yong, W. H., Khanlou, N., Tung, S., & Vinters, H. V. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12977 · Cited by 102
“This has been partially attributed to the tendency toward less-aggressive medical interventions in individuals with dementia.(3,5) Previous studies have examined the causes of death,(6,7) but few have investigated the comorbid conditions associated with mortality and morbidity in individuals with dementia.”
BackgroundWarshaw, G. A., & Bragg, E. J. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.1232 · Cited by 75
Alzheimer’s Disease: A Clinical Practice-Oriented Review
Alves, L., Correia, A. S. A., Miguel, R., Alegria, P., & Bugalho, P. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00063 · Cited by 68
“Nursing home admission by the age of 80 years is expected for ∼75% of the surviving AD patients, and only for 4% of the general population (Arrighi et al., 2010).”
Background2026 Alzheimer's disease facts and figures
(2026) · Alzheimer s & Dementia · doi:10.1002/alz.71345 · Cited by 118
Thinnes, A., & Padilla, R. (2011) · The American Journal of Occupational Therapy · doi:10.5014/ajot.2011.002634 · Cited by 67
Dementia and Alzheimer's Disease among Older Kidney Transplant Recipients
McAdams‐DeMarco, M., Bae, S., Chu, N. M., Gross, A. L., Brown, C. H., Oh, E. S., Rosenberg, P. B., Neufeld, K. J., Varadhan, R., Albert, M., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016080816 · Cited by 69
Evaluation and Management of the Elderly Patient Presenting with Cognitive Complaints
Hildreth, K. L., & Church, S. D. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.11.006 · Cited by 75
Teri, L., Logsdon, R. G., McCurry, S. M., Pike, K. C., & McGough, E. L. (2020) · The Gerontologist · doi:10.1093/geront/gny122 · Cited by 66
Measuring Alzheimer Disease Progression with Transition Probabilities: Estimates from NACC-UDS
Spackman, E., Kadiyala, S., Neumann, P. J., Veenstra, D. L., & Sullivan, S. D. (2012) · Current Alzheimer Research · doi:10.2174/156720512803569046 · Cited by 63
Self-citationPrevalence of Alzheimer Disease in US States
Weuve, J., Hebert, L. E., Scherr, P. A., & Evans, D. A. (2015) · Epidemiology · doi:10.1097/ede.0000000000000199 · Cited by 61
COVID-19 prevalence and mortality in longer-term care facilities
Levin, A., Jylhävä, J., Religa, D., & Shallcross, L. J. (2022) · European Journal of Epidemiology · doi:10.1007/s10654-022-00861-w · Cited by 59
Comorbidity of Late-Life Depression in the United States: A Population-based Study
Manetti, A., Hoertel, N., Strat, Y. L., Schuster, J., Lemogne, C., & Limosin, F. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.05.001 · Cited by 58
“Older adults with a diagnosis of dementia are more often institutionalized: nursing home admission by the age of 80 years is expected for w75% of Alzheimer disease patients.(46) Despite these limitations, this study found no significant interaction between rates of current somatic comorbidity, lifetime and 12-month ps…”
BackgroundMartínez-Pérez, B., Díez, I. D. L. T., López-Coronado, M., & de Abajo, B. S. (2014) · JMIR mhealth and uhealth · doi:10.2196/mhealth.2779 · Cited by 53
The advent of Alzheimer treatments will change the trajectory of human aging
Selkoe, D. J. (2024) · Nature Aging · doi:10.1038/s43587-024-00611-5 · Cited by 57
“At age 80, ~75% of people with AD-linked dementia live in a nursing home, compared with 4% of the general population 87 .”
Nägga, K., Wattmo, C., Zhang, Y., Wahlund, L.-O., & Palmqvist, S. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt271 · Cited by 47
“Introduction Alzheimer’s disease (AD) is strongly associated with an early death, compared with the nondemented elderly population [1-5].”
Systems Delivery Innovation for Alzheimer Disease
Bott, N. T., Sheckter, C. C., Yang, D., Peters, S., Brady, B., Plowman, S., Borson, S., Leff, B., Kaplan, R. M., Platchek, T., et al. (2019) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.09.015 · Cited by 39
Mausbach, B. T., Chattillion, E. A., Ho, J., Flynn, L. M., Tiznado, D., von Känel, R., Patterson, T. L., & Grant, I. (2014) · Psychology and Aging · doi:10.1037/a0037626 · Cited by 36
End‐of‐Life Decisions in Individuals Dying with Dementia in Belgium
Chambaere, K., Cohen, J., Robijn, L., Bailey, S. K., & Deliëns, L. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13255 · Cited by 38
Pharmacotherapeutic strategies in the treatment of severe Alzheimer’s disease
Deardorff, W. J., & Grossberg, G. T. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1215431 · Cited by 34
“People with AD aged 65 and older will survive an average of 4–8 years after the initial diagnosis, with more time spent in the severe stage than any other stage [2].”
BackgroundWarrillow, S. J., Moran, J. A., & Weickhardt, A. J. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1509349 · Cited by 32
Fields, N. L., Xu, L., & Miller, V. J. (2019) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317519826217 · Cited by 34
Palliative Care of the Patient with Dementia
Malhi, R. K. S., McElveen, J. L., & O’Donnell, L. (2021) · Delaware Journal of Public Health · doi:10.32481/djph.2021.09.012 · Cited by 35
Executive functions assessment in patients with language impairment A systematic review
Gonçalves, A. P. B., Mello, C., Pereira, A. H., Ferré, P., Fonseca, R. P., & Joanette, Y. (2018) · Dementia & Neuropsychologia · doi:10.1590/1980-57642018dn12-030008 · Cited by 30
Family Caregiver Perspectives on Suffering of Persons With Severe Dementia: A Qualitative Study
Malhotra, C., Hazirah, M., Tan, L. L., Malhotra, R., Yap, P. L. K., Balasundaram, B., Tong, K.-M., & Pollak, K. I. (2020) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2020.11.021 · Cited by 26
Postoperative cognitive dysfunction and Alzheimer disease
Işık, B. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1405-87 · Cited by 27
“The most widely employed strategy is symptomatic treatment with cholinergic agents, such as acetylcholine (ACh), and monoamines, neuropeptides, and metabolic enhancers (14,16,17,19).”
BackgroundFink, A., Buchmann, N., Tegeler, C., Steinhagen‐Thiessen, E., Demuth, I., & Doblhammer, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187119 · Cited by 25
Gin, A. N., Nguyen, P.-D., Serrano, G. E., Alexander, G. E., & Su, J. (2024) · npj Biosensing · doi:10.1038/s44328-024-00009-8 · Cited by 23
“S.,andforpeopleaboveage70,61%of thosewithADareexpectedtodiebefore80comparedto30%ofpeople withoutthedisease 3 .”
Brucki, S. M. D., Aprahamian, I., Borelli, W. V., Calil, V., Ferretti‐Rebustini, R. E. D. L., Smid, J., Barbosa, B. J. A. P., Schilling, L. P., Balthazar, M. L. F., Frota, N. A. F., et al. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-s107pt · Cited by 34
Dementia’s Unique Burden: Function and Health Care in the Last 4 Years of Life
Broyles, I., Li, Q., Palmer, L., DiBello, M., Dey, J., de Oliveira, I. C., & Lamont, H. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad003 · Cited by 18
Tompkins, C. J., Ihara, E. S., Inoue, M., Ferenz, J., & Pham, S. (2019) · Gerontology & Geriatrics Education · doi:10.1080/02701960.2019.1699074 · Cited by 18
Exploring Pathways to Caregiver Health: The Roles of Caregiver Burden, Familism, and Ethnicity
Mehdipanah, R., Briceño, E. M., Malvitz, M., Chang, W., Lewandowski-Romps, L. M., Heeringa, S. G., Levine, D. A., Zahuranec, D. B., Langa, K. M., Gonzales, X. F., et al. (2024) · Journal of Aging and Health · doi:10.1177/08982643241235970 · Cited by 17
“Cognitive decline, high levels of caregiver burden, and behavioral problems have been associated with increased likelihood of transition to nursing homes (Arrighi et al., 2010; Kesselring et al., 2001).”
Zhou, Y. C., Putter, H., & Doblhammer, G. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0184-7 · Cited by 18
“The underlying mechanisms might be that LEI speeds up the course of dementia [48], or that dementia slows down functional recovery after LEI, thus increasing care need in patients with dementia [34, 49].”
BackgroundLapane, K. L., Dube, C. E., Jesdale, B. M., & Bova, C. (2022) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000525343 · Cited by 20
Deardorff, W. J., Jeon, S. Y., Barnes, D. E., Boscardin, W. J., Langa, K. M., Covinsky, K. E., Mitchell, S. L., Lee, S. J., & Smith, A. K. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.6548 · Cited by 16
Saks, K., Tiit, E., Verbeek, H., Raamat, K., Armolik, A., Leibur, J., Meyer, G., Zabalegui, A., Leino‐Kilpi, H., Karlsson, S., et al. (2014) · Journal of Advanced Nursing · doi:10.1111/jan.12544 · Cited by 16
Fields, N. L., Xu, L., Richardson, V., Parekh, R., Ivey, D. L., & Calhoun, M. (2019) · Dementia · doi:10.1177/1471301219871192 · Cited by 17
Bova, C., Jesdale, B. M., Mbrah, A. K., Botelho, L., & Lapane, K. L. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5516 · Cited by 16
Brunton, S., Pruzin, J. J., Alford, S., Hamersky, C. M., Sabharwal, A. K., & Gopalakrishna, G. (2023) · Postgraduate Medicine · doi:10.1080/00325481.2023.2217025 · Cited by 15
Empowering a person‐centered long‐term care workforce
Pace, D., Betts, S., Reda, L., Griff, M., Stratton, L., Shubeck, E., Eichenberger, L., Holles, N., Holloway, L., Little, R., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14111 · Cited by 16
Alexander, C. M., Martyr, A., & Clare, L. (2022) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5702 · Cited by 15
“Receiving a dementia diagnosis has immediate implications for the person diagnosed and their family, with a prognosis of ongoing decline in abilities affecting future independence, relationships, living situation, finances and ultimately, reducing life expectancy.(1,2) People with dementia do not all acknowledge their…”
BackgroundAssessing awareness in severe Alzheimer’s disease
Huntley, J. D., Bor, D., Deng, F., Mancuso, M., Mediano, P. A. M., Naçi, L., Owen, A. M., Rocchi, L., Sternin, A., & Howard, R. J. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.1035195 · Cited by 16
“A person who lives for 10 years with AD spends an average of 40% of this time with severe AD (Arrighi et al., 2010).”
BackgroundAge-Friendly Health Systems for Older Adults With Dementia
Fulmer, T. T., & Li, N. (2017) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2017.09.001 · Cited by 16
Borelli, W. V., Ferreira, P. C. L., Brum, W. S., Ferrari‐Souza, J. P., Carello‐Collar, G., Holz, M. R., Souza, V. T., Strelow, M. Z., Formoso, C., Chaves, M. L. F., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03192-w · Cited by 14
Day, G. S. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001507 · Cited by 15
Fink, A., Dörre, A., Demuth, I., & Doblhammer, G. (2022) · BMC Neurology · doi:10.1186/s12883-022-02682-6 · Cited by 12
“There is a long period of care dependency over the course of the illness, as dementia patients spend 30% of their remaining life expectancy in the moderate stage of the illness, and 40% in the most severe stage of the illness [43].”
BackgroundA Model of Risk Reduction for Older Adults Vulnerable to Nursing Home Placement
Palmer, J. L., Langan, J. C., Krampe, J., Krieger, M., Lorenz, R. A., Schneider, J. K., Smith, J. M., & Lach, H. W. (2014) · Research and theory for nursing practice · doi:10.1891/1541-6577.28.2.162 · Cited by 14
Trends in healthy days at home for Medicare beneficiaries using the emergency department
Burke, L. G., Burke, R. C., Duggan, C. E., Figueroa, J. F., Orav, E. J., & Marcantonio, E. R. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18464 · Cited by 11
“Individuals with AD/ADRD, in particular, have higher rates of long-term NH utilization as their disease progresses.(31) We repeated our models with 30-day HDAH in 2017 and 2018 incorporating beneficiary AD/ADRD status, NH residency status, and an interaction between the two to examine if the association between AD/ADR…”
MethodXu, L., Lee, Y., Kim, B. J., & Chen, L. (2020) · Home Health Care Services Quarterly · doi:10.1080/01621424.2020.1805083 · Cited by 9
Jicha, G. A., Tucker, T. C., Arnold, S. M., & Nelson, P. T. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01532-6 · Cited by 7
“As described in the Alzheimer’s Facts and Figures 2021 [5]: “A person who lives from age 70 to age 80 with Alzheimer’s dementia will spend an average of 40% of this time in the severe stage [7].”
BackgroundKadlec, H., Dujela, C., Beattie, B. L., & Chappell, N. L. (2016) · Aging & Mental Health · doi:10.1080/13607863.2016.1226766 · Cited by 7
“Furthermore, over half of newly diagnosed patients with AD are estimated to die within eight years of their initial diagnosis, and almost 70% of the survivors will be in a nursing home (Arrighi et al., 2010).”
BackgroundFink, A., & Doblhammer, G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142082 · Cited by 7
“On average, dementia patients spend 30% of their remaining life expectancy in the moderate stage of the illness, and 40% in the most severe stage of the illness [18].”
Real-world effects of anti-dementia treatment on mortality in patients with Alzheimer´s dementia
Nielsen, R. E., Grøntved, S., Lolk, A., Andersen, K., & Valentin, J. B. (2022) · Medicine · doi:10.1097/md.0000000000031625 · Cited by 6
“[3] Patients with AD spend a considerable portion of the time from diagnosis till end of life in a state of severe dementia resulting in either nursing home care or dependence on caregivers at home.[3,5] Symptomatic pharmacological treatment of dementia in connection with Alzheimer ́s disease consists of acetylcholine…”
BackgroundZhang, L., Ngo, A. D., Thomas, J., Burkhardt, H. A., Parsey, C. M., Au, R., & Ghomi, R. H. (2021) · Exploration of Medicine · doi:10.37349/emed.2021.00044 · Cited by 6
“AD is the sixth leading cause of death in the United States and the fifth leading cause of death among Americans age 65 and older [2].”
BackgroundMartin, P., Poon, L. W., Lee, G., Obhi, H. K., Kallianpur, K. J., Willcox, B. J., & Masaki, K. (2022) · Journal of Aging and Health · doi:10.1177/08982643221130381 · Cited by 6
“Older adults with cognitive impairment have an increased risk of functional dependence, hospitalization, institutionalization, and death (Arrighi et al., 2010; Miller & Weissert, 2000; Yaffe et al., 2010).”
BackgroundRadiomics of PET Using Neural Networks for Prediction of Alzheimer's Disease Diagnosis
Zhang, Y., Steingrimsson, J. A., Ambekar, A., Oh, H., Eloyan, A., & Initiative, A. D. N. (2025) · Statistics in Medicine · doi:10.1002/sim.70128 · Cited by 6
“Patients with AD between 70 to 80 years old typically spend 4 years in severe stage of disease [5].”
Shin, S. H. (2021) · The Journal of the Economics of Ageing · doi:10.1016/j.jeoa.2021.100327 · Cited by 5
Neves, B. A., Nunes, P. V., Rodriguez, R. D., Haidar, A. M., Leite, R. E. P., Nascimento, C. F., Pasqualucci, C. A., Nitríni, R., Filho, W. J., Lafer, B., et al. (2022) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000489 · Cited by 5
“We divided participants into 6 groups: (1) AD; (2) VaD; (3) DLB; (4) AD+VaD; (5) other types of dementia; (6) without dementia.”
BackgroundInfluentialYuan, L., Ye, J., Wang, W., Xiao, A., Ying, Z., Lin, W., Wei, Y., Smith, G. D., Wu, J., Tang, Q., et al. (2024) · ALPHA PSYCHIATRY · doi:10.5152/alphapsychiatry.2023.1470 · Cited by 5
“42,43 Empirical studies showed that the quality of life was related to cognitive function and communication in dementia patients.”
BackgroundQin, X., Baker, Z. G., Jarosek, S. L., Woodhouse, M., Chu, H., McCarthy, T. C., & Shippee, T. P. (2021) · Innovation in Aging · doi:10.1093/geroni/igab024 · Cited by 4
“Between 75% and 90% of persons with ADRD will need a nursing home (NH)-level care (2,3), and up to 50% of NH residents have ADRD, creating a mandate to understand quality of care in NHs among residents with ADRD (4).”
BackgroundThe QPLEX™ Plus Assay Kit for the Early Clinical Diagnosis of Alzheimer’s Disease
Na, H., Shin, K. Y., Lee, D., Yoon, C., Han, S., Park, J., Mook‐Jung, I., Jang, J. S., & Kwon, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311119 · Cited by 4
“5 as questionable, 1 as mild dementia, and 2 or more as dementia [38].”
BackgroundLapane, K. L., Ott, B. R., Hargraves, J. L., Cosenza, C. A., Liang, S., & Alcusky, M. J. (2023) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2023.09.022 · Cited by 4
Dysphagia in Persons with Dementia: The Dual Diagnosis Challenge
Tristani, M. (2016) · Perspectives of the ASHA Special Interest Groups · doi:10.1044/persp1.sig15.105 · Cited by 3
Group-Based Participatory Arts Interventions Validate Personhood for those Living with Dementia
Kaplan, D. B., Glazner, G., & Drake, C. G. (2023) · Advances in Social Science and Culture · doi:10.22158/assc.v5n2p1 · Cited by 3
Lewis, L. F. (2014) · OpenCommons - UConn (University of Connecticut) · Cited by 3
Iversen, W. L., Monroe, T. B., Atalla, S., Anderson, A. R., Cowan, R. L., Wright, K., Failla, M. D., & Moss, K. O. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.926459 · Cited by 2
“The three-item capacity questionnaire described by Palmer and colleagues consists if the following questions: (1) “What is the purpose of the study?” (2) “What are the risks?” and (3) “What are the benefits?” (24) Similarly, Monroe and colleagues uses the following 3 questions to assess decisional capacity to”
BackgroundInfluentialBrucki, S. M. D., Aprahamian, I., Borelli, W. V., Calil, V., Ferretti‐Rebustini, R. E. D. L., Smid, J., Barbosa, B. J. A. P., Schilling, L. P., Balthazar, M. L. F., Frota, N. A. F., et al. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-s107en · Cited by 3
“Around 30 to 60% of patients with dementia (PWD) and 90% of individuals residing in long-term care facilities are in its moderate-late stage 3-5 .”
BackgroundInfluentialA Pragmatic Approach to the Postmortem Neuropathological Diagnosis of Dementia
Reichard, R. R., & Parisi, J. E. (2012) · Academic Forensic Pathology · doi:10.23907/2012.001 · Cited by 2
Residents' and Family Perspectives of Involuntary Healthcare Facility Closure and Relocation
Weaver, R. H., Roberto, K. A., Brossoie, N., & Teaster, P. B. (2022) · Journal of Elder Policy · doi:10.18278/jep.2.1.4 · Cited by 2
FEASIBILITY OF HAIR CORTISOL AS A BIOMARKER OF WELL-BEING IN OLDER ADULTS WITH DEMENTIA
Kim, E. (2019) · Research Exchange (Washington State University) · Cited by 2
Nursing home placement in Norway - Characteristics of older people assigned to placement
Henriksen, N. O., Fjelltun, A. S., Normann, H. K., & Norberg, A. (2015) · Nordisk Sygeplejeforskning · doi:10.18261/issn1892-2686-2015-02-06 · Cited by 2
Stage of Disease Among Hospitalized Persons Living With Dementia: A Multisite Study
Lynch, D. H., Lynch, M., Wessell, K. L., Lin, F.-C., Toles, M., Mitchell, S., & Hanson, L. C. (2026) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2026.106183 · Cited by 2
Gilbert, M. (2015) · Digital Commons - USU (Utah State University) · doi:10.26076/0068-83db · Cited by 1
Metadata
- Authors
- Arrighi, H. M., Neumann, P. J., Lieberburg, I. M., & Townsend, R. J.
- Affiliations
- Elan Pharmaceuticals, Inc. (Ireland) (IE)
- Tufts Medical Center (US)
- University of California, San Francisco (US)
- Corresponding author
- Arrighi, Henry Michael
- Lieberburg, Ivan M.
- Townsend, Raymond J.
- ORCID
- Neumann, Peter J.
- Venue
- Alzheimer Disease & Associated Disorders
- Published
- 2010-01
- Volume
- 24
- Issue
- 1
- Pages
- 90-95
- ISSN
- 0893-0341 (ISSN-L)
- OpenAlex
- W2094938161
- Cited by
- 126
- References
- 36
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 9 · 2023: 10 · 2022: 14 · 2021: 11 · 2020: 6 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 7 · 2015: 14 · 2014: 11 · 2013: 6 · 2012: 4
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Alzheimer Disease & Associated Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, mortality, nursing home admission, life expectancy, Clinical Dementia Rating, disease progression, survival estimates, mortality trends, older adults
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Female, Homes for the Aged, Humans, Life Expectancy, Male, Nursing Homes, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.